Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Rilpivirine

A non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV, approved in the United States in 2011. It is used in combination with other antiretrovirals, including in single tablets that combine several active ingredients. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Together with cabotegravir, in 2021 it became part of the first complete long-acting HIV regimen approved in the United States: periodic intramuscular injections instead of daily tablets.

RilpivirineGo to the active ingredient →
RilpivirineActive ingredientRilpivirineCat. No. P-R059-001CAS 500287-72-9
Rilpivirine-D6Isotopically labelledRilpivirine-D6Cat. No. P-R059-004CAS 1312424-26-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.